Michael Kreiberg

577 total citations
28 papers, 364 citations indexed

About

Michael Kreiberg is a scholar working on Surgery, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Michael Kreiberg has authored 28 papers receiving a total of 364 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Surgery, 18 papers in Molecular Biology and 7 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Michael Kreiberg's work include Testicular diseases and treatments (24 papers), Sexual Differentiation and Disorders (16 papers) and Hormonal and reproductive studies (7 papers). Michael Kreiberg is often cited by papers focused on Testicular diseases and treatments (24 papers), Sexual Differentiation and Disorders (16 papers) and Hormonal and reproductive studies (7 papers). Michael Kreiberg collaborates with scholars based in Denmark, United Kingdom and Australia. Michael Kreiberg's co-authors include Jakob Lauritsen, Mikkel Bandak, Gedske Daugaard, Thomas Wagner, Mads Agerbæk, Niels V. Holm, Søren Jessen, Morten Hostrup, Vibeke Backer and Jens Bangsbo and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Physiology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Michael Kreiberg

27 papers receiving 362 citations

Peers

Michael Kreiberg

SURGE

PPCH

ASZ

PHYSI

John B. Tourtelot United States

Shrikrishna V. Acharya India

Päivi Kekäläinen Finland

Linn E. Moore Canada

Hasan Hüseyin Tavukçu Türkiye

C.C. Alevizaki Greece

Sara Zullino Italy

Giacomo Accardo Italy

C. Wüster Germany

Ole Djøseland Norway

John B. Tourtelot United States

Michael Kreiberg

119 ×0.6

SURGE

118 ×1.3

41 ×0.7

PPCH

12 ×0.2

ASZ

29 ×0.5

PHYSI

Citations per year, relative to Michael Kreiberg Michael Kreiberg (= 1×) peers John B. Tourtelot

Countries citing papers authored by Michael Kreiberg

Since Specialization

Citations

This map shows the geographic impact of Michael Kreiberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Kreiberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Kreiberg more than expected).

Fields of papers citing papers by Michael Kreiberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Kreiberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Kreiberg. The network helps show where Michael Kreiberg may publish in the future.

Co-authorship network of co-authors of Michael Kreiberg

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Kreiberg. A scholar is included among the top collaborators of Michael Kreiberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Kreiberg. Michael Kreiberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wagner, Thomas, Birgitte Grønkær Toft, Jakob Lauritsen, et al.. (2024). Prognostic factors for relapse in patients with clinical stage I testicular non-seminoma: A nationwide, population-based cohort study. European Journal of Cancer. 202. 114025–114025. 6 indexed citations

Jørgensen, Poul, Michael Kreiberg, Niels Jørgensen, et al.. (2023). Effect of 12-months testosterone replacement therapy on bone mineral density and markers of bone turnover in testicular cancer survivors – results from a randomized double-blind trial. Acta Oncologica. 62(7). 689–695. 2 indexed citations

Bandak, Mikkel, Michael Kreiberg, Thomas Wagner, et al.. (2023). Smoking as a prognostic factor for survival in patients with disseminated germ cell cancer. JNCI Journal of the National Cancer Institute. 115(6). 753–756. 1 indexed citations

Wagner, Thomas, Jakob Lauritsen, Mikkel Bandak, et al.. (2023). A Validated Algorithm for Register-Based Identification of Patients with Relapse of Clinical Stage I Testicular Cancer. Clinical Epidemiology. Volume 15. 447–457. 1 indexed citations

Jørgensen, Niels, Anders Juul, Jakob Albrethsen, et al.. (2023). Insulin-like Factor 3, Basal and Human Chorionic Gonadotropin-Stimulated Testosterone as Biomarkers to Predict the Effect of Testosterone Replacement in Testicular Cancer Survivors With Mild Leydig Cell Insufficiency. Clinical Genitourinary Cancer. 22(1). e106–e112.e4. 1 indexed citations

Kreiberg, Michael, Niels Jørgensen, Anders Juul, et al.. (2022). A randomized double-blind single center study of testosterone replacement therapy or placebo in testicular cancer survivors with mild Leydig cell insufficiency (Einstein-intervention). Clinical Genitourinary Cancer. 20(5). 404–414. 4 indexed citations

Kreiberg, Michael, Christian Dehlendorff, Niels Jørgensen, et al.. (2022). Effect of Testosterone Replacement Therapy on Quality of Life and Sexual Function in Testicular Cancer Survivors With Mild Leydig Cell Insufficiency: Results From a Randomized Double-blind Trial. Clinical Genitourinary Cancer. 20(4). 334–343. 6 indexed citations

Chovanec, Michal, Jakob Lauritsen, Mikkel Bandak, et al.. (2021). Late adverse effects and quality of life in survivors of testicular germ cell tumour. Nature Reviews Urology. 18(4). 227–245. 51 indexed citations

Priskorn, Lærke, Michael Kreiberg, Mikkel Bandak, et al.. (2021). Testicular cancer survivors have shorter anogenital distance that is not increased by 1 year of testosterone replacement therapy. Human Reproduction. 36(9). 2443–2451. 9 indexed citations

10.

Bandak, Mikkel, Allan Jensen, Christian Dehlendorff, et al.. (2021). Paternity After Treatment for Testicular Germ Cell Cancer: A Danish Nationwide Population-Based Cohort Study. JNCI Journal of the National Cancer Institute. 114(1). 149–155. 7 indexed citations

11.

Lauritsen, Jakob, Mikkel Bandak, Michael Kreiberg, et al.. (2020). Long-term neurotoxicity and quality of life in testicular cancer survivors—a nationwide cohort study. Journal of Cancer Survivorship. 15(4). 509–517. 17 indexed citations

12.

Jessen, Søren, Søren Reitelseder, Anders Kalsen, et al.. (2020). β₂-Adrenergic agonist salbutamol augments hypertrophy in MHCIIa fibers and sprint mean power output but not muscle force during 11 weeks of resistance training in young men. Journal of Applied Physiology. 130(3). 617–626. 21 indexed citations

13.

Kreiberg, Michael, Mikkel Bandak, Jakob Lauritsen, et al.. (2019). Psychological stress in long-term testicular cancer survivors: a Danish nationwide cohort study. Journal of Cancer Survivorship. 14(1). 72–79. 17 indexed citations

14.

Wagner, Thomas, Birgitte Grønkær Toft, Jakob Lauritsen, et al.. (2019). Prognostic factors for relapse in patients with clinical stage I testicular cancer: protocol for a Danish nationwide cohort study. BMJ Open. 9(10). e033713–e033713. 9 indexed citations

15.

Lauritsen, Jakob, Merete Kjær Hansen, Mikkel Bandak, et al.. (2019). Cardiovascular Risk Factors and Disease After Male Germ Cell Cancer. Journal of Clinical Oncology. 38(6). 584–592. 50 indexed citations

16.

Hostrup, Morten, Søren Reitelseder, Søren Jessen, et al.. (2018). Beta ₂ ‐adrenoceptor agonist salbutamol increases protein turnover rates and alters signalling in skeletal muscle after resistance exercise in young men. The Journal of Physiology. 596(17). 4121–4139. 44 indexed citations

17.

Lauritsen, Jakob, et al.. (2018). Quality of Life in Long-Term Testicular Cancer Survivors With Compensated Leydig Cell Dysfunction. Clinical Genitourinary Cancer. 17(1). e65–e71. 6 indexed citations

18.

Kreiberg, Michael, Mikkel Bandak, Jakob Lauritsen, et al.. (2018). Cohort Profile: The Danish Testicular Cancer Late Treatment Effects Cohort (DaTeCa-LATE). Frontiers in Oncology. 8. 37–37. 11 indexed citations

19.

Bandak, Mikkel, Niels Jørgensen, Anders Juul, et al.. (2017). A randomized double-blind study of testosterone replacement therapy or placebo in testicular cancer survivors with mild Leydig cell insufficiency (Einstein-intervention). BMC Cancer. 17(1). 461–461. 10 indexed citations

20.

Onslev, Johan, Glenn A. Jacobson, Christian Narkowicz, et al.. (2017). Beta2-adrenergic stimulation increases energy expenditure at rest, but not during submaximal exercise in active overweight men. European Journal of Applied Physiology. 117(9). 1907–1915. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact